Novartis Says Experimental MS Pill Reduced Flare-Ups in Two Late-Stage Trials

Novartis said its experimental multiple sclerosis pill significantly reduced symptom flare-ups in the most common form of the disease and showed a favorable safety profile in two late-stage studies.